Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA)

OBJECTIVES: To evaluate the long-term efficacy and safety of subcutaneous (SC) tocilizumab (TCZ) versus intravenous (IV) TCZ, including switching formulations, in patients with rheumatoid arthritis (RA) and inadequate response to disease-modifying antirheumatic drugs (DMARDs). METHODS: Patients (n=1...

Descripción completa

Detalles Bibliográficos
Autores principales: Burmester, Gerd R, Rubbert-Roth, Andrea, Cantagrel, Alain, Hall, Stephen, Leszczynski, Piotr, Feldman, Daniel, Rangaraj, Madura J, Roane, Georgia, Ludivico, Charles, Bao, Min, Rowell, Lucy, Davies, Claire, Mysler, Eduardo F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717437/
https://www.ncbi.nlm.nih.gov/pubmed/26056119
http://dx.doi.org/10.1136/annrheumdis-2015-207281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717437/
https://www.ncbi.nlm.nih.gov/pubmed/26056119
http://dx.doi.org/10.1136/annrheumdis-2015-207281

Ejemplares similares